CLOs on the Move

Lyell

www.lyell.com

 
We are entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. While enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. Cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers. Our goal is nothing less than to develop curative cell-based therapies for solid tumor cancers.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.lyell.com
  • 201 Haskins Way
    South San Francisco, CA USA 94080
  • Phone: 650.695.0677

Executives

Name Title Contact Details
Stasiu Nowak
 Director, Intellectual Property Profile
Julie Urvater
 Senior Director, Intellectual Property Profile
Krista Cosner
 Vice President of Legal Profile
Kimberly Henson
 Associate Director, Contracts and Legal Services Profile
Rahsaan Thompson
 Chief Legal Officer Profile

Similar Companies

Datavant

Datavant connects healthcare data to eliminate the silos of healthcare information that hold back innovative medical research and improved patient care. We help data owners manage the privacy, security, compliance, and trust required to enable safe data sharing. Datavant`s vision is backed by Roivant Sciences, Softbank, and Founders Fund, and combines technical leadership and healthcare expertise. Datavant is located in the heart of San Francisco`s Financial District.

FibroBiologics

Enzymatics

Enzymatics is a Beverly, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Progenika

Progenika is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

GVB Biopharma

GVB Biopharma operates two state-of-the-art hemp extraction and white labeling facilities in Central Oregon and Las Vegas, Nevada.